September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Metamorphopsia and vision-related quality of life among patients with age-related macular degeneration (AMD)
Author Affiliations & Notes
  • Kunyong Xu
    Ophthalmology, Queen's University, Kingston, Ontario, Canada
  • Vasudha Gupta
    Ophthalmology, Queen's University, Kingston, Ontario, Canada
  • Steven Bae
    Ophthalmology, Queen's University, Kingston, Ontario, Canada
  • Sanjay Sharma
    Ophthalmology, Queen's University, Kingston, Ontario, Canada
  • Footnotes
    Commercial Relationships   Kunyong Xu, None; Vasudha Gupta, None; Steven Bae, None; Sanjay Sharma, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2660. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kunyong Xu, Vasudha Gupta, Steven Bae, Sanjay Sharma; Metamorphopsia and vision-related quality of life among patients with age-related macular degeneration (AMD). Invest. Ophthalmol. Vis. Sci. 2016;57(12):2660.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : 1) To quantify metamorphopsia; 2) to assess vision-related quality of life (QoL); and 3) to investigate the correlation between metamorphopsia and QoL among patients with AMD.

Methods : AMD patients at the Department of Ophthalmology, Hotel Dieu Hospital, were invited to participate in this cross-sectional study. Patients who had a best corrected visual acuity (BCVA) less than 20/200, vitreomacular adhesion, vitreomacular traction, epiretinal membrane, macular hole, macular edema by causes other than AMD, diabetic retinopathy, retinal detachment, previous retinal surgery, glaucoma, amblyopia, or strabismus were excluded. M-CHARTS (Inami, Japan) was used to quantify the minimum visual angle of a dotted line needed to detect metamorphopsia. The examination distance was 30 centimeters, and the refraction of the eye was adjusted to this distance. Metamorphopsia was scored horizontally (MH) and vertically (MV). The mean values of three repeated examinations were used for data analysis. The 25-item National Eye Institute Visual Functioning Questionnaire (VFQ-25) was used to assess vision-related QoL.

Results : 30 eyes (53.3% wet AMD and 46.7% dry AMD) of 30 patients were included. Patients were Caucasian (100%) and female predominant (63.3%) with a mean age of 77.0 years (SD= 8.30). The BCVA for near and for distance was 0.50 logMAR (SD=0.27) and 0.49 logMAR (0.25), respectively. The mean score for MV and MH was 0.37 (SD=0.27) and 0.40 (SD=0.32), respectively. The mean score for VFQ-25 was 83.4 (SD= 13.5). Subscales of VFQ-25 with lower mean scores included general health (61.7, SD=23.4), general vision (74.7, SD=11.7), near vision (75.6, SD=20.2), vision-related mental health (79.8, SD=12.4), and distance vision (81.8, SD=20.2). The MV (r1) and MH (r2) scores were correlated with the mean score of VFQ-25 (Spearman rank correlation: r1=-0.39, p=0.0341; and r2=-0.40, p=0.0265, respectively). In addition, MV and MH scores were negatively correlated with VFQ-25 subscales, such as near vision, distance vision, social function, mental health, and peripheral vision.

Conclusions : In our study, AMD patients had slightly higher horizontal versus vertical metamorphopsia quantified using M-CHARTS. The most commonly affected QoL included general health, general vision, near vision, mental health, and distance vision. Quantified metamorphosia and QoL among AMD patients were negatively correlated.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×